Zoetis (ZTS)CEO sold ~$1.16M

~$1.16M

Approx. value · 9,200 sh @ $126.46

112K

Holds after · shares reported

Traded

Feb 17, 2026

Filed

Feb 17, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Dec 19, 2025Congress · 1 personMembers of Congress: 2 purchases
2. Jan 7, 20265% stakeThe Vanguard Group reported a passive stake (13G) of 10.8%
3. Feb 6, 2026Government · Federal Register ruleNew Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of Sponsor; Change of Sponsor Address
4. Feb 10, 2026CongressDisclosed purchase of ZTS — reported range $1,001 - $15,000
5. Feb 12, 2026Company filing · Form 8-K · ResultsReported its results
6. Feb 17, 2026 · this disclosureInsiderCEO sold ~$1.16M of ZTS shares in the open market

What came next

1. Feb 17, 2026InsiderCEO sold ~$1.38M of ZTS shares in the open market
2. Mar 13, 2026CongressDisclosed partial sale of ZTS — reported range $1,001 - $15,000
3. Mar 18, 2026Federal contract · $382 obligatedDepartment of Defense awarded Zoetis: $382 obligated to date
4. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
5. Apr 13, 2026Federal contract · $100K obligatedDepartment of Agriculture awarded Zoetis: $100K obligated to date
6. Apr 14, 2026CongressDisclosed partial sale of ZTS — reported range $1,001 - $15,000
7. Apr 21, 2026Federal contract · $627K obligatedDepartment of Agriculture awarded Zoetis: $627K obligated to date
8. Apr 29, 20265% stakeVanguard Portfolio Management reported a passive stake (13G) of 5.7%
9. Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.2%
10. May 7, 2026Company filing · Form 8-K · ResultsReported its results
11. May 8, 2026Federal contract · $484K obligatedDepartment of Agriculture awarded Zoetis: $484K obligated to date
12. May 11, 2026Insider · 9 days before an 8-KDirector purchased ~$233K of ZTS shares in the open market
13. May 13, 2026Insider · 2 peopleInsiders: 2 purchases (~$653K)
14. May 20, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“Effective May 20, 2026, Ms. Louise M. Parent retired from the Board of Directors of Zoetis Inc. (the “Company”), prior to the Company’s 2026 Annual Meeting of Shareholders (the “Annual Meeting”) in accordance with the Company’s director retirement policy.”
15. May 27, 2026Court · District Court, S.D. New YorkSecurities lawsuit filed: City of Ann Arbor Retiree Health Care Benefit Plan & Trust v. Zoetis Inc.

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Zoetis

For Zoetis, OQRO holds 3 Congress trade reports, 53 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ZTS page.

Other recent filings by Kristin C Peck, Chief Executive Officer

• SEC Form 4 at Zoetis (ZTS)Feb 17, 2026
• SEC Form 4 at Zoetis (ZTS)Feb 20, 2025

The full history of Kristin C Peck, Chief Executive Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Zoetis

• USAspending.gov award recordSep 14, 2026
• House Clerk periodic transaction reportSep 4, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its ZTS page.